The IQ Working Group has defined a pragmatic risk-based approach to audit trail review, where it is only required for high impact GxP data.
Katria Harasewych
Advertisement
Katria Harasewych, quality, Merck & Co., Inc., Kenilworth, NJ
Articles by Katria Harasewych
A data-integrity risk assessment tool has been developed for use with standalone R&D data-acquisition and processing software.
Advertisement
Latest Updated Articles
A Harmonized Approach to Performing a Risk-Based Audit Trail ReviewPublished: September 2nd 2022 | Updated:
Assessing Data Integrity Risks in an R&D EnvironmentPublished: August 2nd 2020 | Updated:
Advertisement
Advertisement
Trending on Pharmaceutical Technology
1
AAPS PharmSci 360 2025: The Role of LC–MS in Bioanalysis
2
Behind the Headlines Episode 28: Navigating FDA Shakeups and Obesity Drug Wars
3
Why Investment Strategies Matter for Advancing Pharmaceutical Technologies
4
PharmTech Weekly News Roundup – Week of November 3, 2025
5
